Clinical Laserthermia Systems AB (publ) (STO:CLS.B)

Sweden flag Sweden · Delayed Price · Currency is SEK
5.62
+0.12 (2.18%)
At close: Mar 6, 2026
53.55%
Market Cap 175.17M
Revenue (ttm) 17.49M
Net Income (ttm) -41.61M
Shares Out 31.17M
EPS (ttm) -1.61
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 41,685
Average Volume 221,852
Open 5.49
Previous Close 5.50
Day's Range 5.35 - 5.67
52-Week Range 2.43 - 13.36
Beta -0.10
RSI 39.25
Earnings Date Feb 20, 2026

About STO:CLS.B

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices. Clinic... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2006
Employees 13
Stock Exchange Nasdaq Stockholm
Ticker Symbol CLS.B
Full Company Profile

Financial Performance

In 2025, STO:CLS.B's revenue was 17.49 million, a decrease of -6.90% compared to the previous year's 18.78 million. Losses were -41.61 million, -12.62% less than in 2024.

Financial Statements

News

Clinical Laserthermia Systems AB (FRA:LS60) Q3 2025 Earnings Call Highlights: Strategic ...

Clinical Laserthermia Systems AB (FRA:LS60) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges

4 months ago - GuruFocus

Q3 2025 Clinical Laserthermia Systems AB Earnings Call Transcript

Q3 2025 Clinical Laserthermia Systems AB Earnings Call Transcript

4 months ago - GuruFocus